Labcorp Holdings annual current ratio
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Current Ratio Growth & History (LH)
Labcorp Holdings's current ratio was 1.42 for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.42 | −0.02 | −1.34% |
| 2024 | 2024-12-31 | 1.44 | 0.28 | +23.62% |
| 2023 | 2023-12-31 | 1.17 | −0.33 | −22.29% |
| 2022 | 2022-12-31 | 1.50 | −0.41 | −21.57% |
| 2021 | 2021-12-31 | 1.92 | 0.25 | +15.05% |
| 2020 | 2020-12-31 | 1.66 | 0.54 | +48.32% |
| 2019 | 2019-12-31 | 1.12 | −0.39 | −25.62% |
| 2018 | 2018-12-31 | 1.51 | 0.26 | +20.65% |
| 2017 | 2017-12-31 | 1.25 | −0.11 | −7.78% |
| 2016 | 2016-12-31 | 1.36 | −0.19 | −12.01% |
| 2015 | 2015-12-31 | 1.54 | −0.19 | −11.09% |
| 2014 | 2014-12-31 | 1.73 | −0.21 | −10.93% |
| 2013 | 2013-12-31 | 1.95 | 0.59 | +43.85% |
| 2012 | 2012-12-31 | 1.35 | −0.09 | −6.47% |
| 2011 | 2011-12-31 | 1.45 | 0.43 | +41.74% |
| 2010 | 2010-12-31 | 1.02 | 0.10 | +11.11% |
| 2009 | 2009-12-31 | 0.92 | −0.97 | −51.35% |
| 2008 | 2008-12-31 | 1.89 | — | — |
Labcorp Holdings quarterly current ratio
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.80 | 0.29 | +19.35% |
| Q1 2026 | 2026-03-31 | 1.73 | −0.11 | −5.96% |
| Q4 2025 | 2025-12-31 | 1.42 | −0.02 | −1.34% |
| Q3 2025 | 2025-09-30 | 1.55 | 0.11 | +7.81% |
| Q2 2025 | 2025-06-30 | 1.50 | 0.63 | +71.23% |
| Q1 2025 | 2025-03-31 | 1.84 | 0.96 | +109.31% |
| Q4 2024 | 2024-12-31 | 1.44 | 0.28 | +23.62% |
| Q3 2024 | 2024-09-30 | 1.44 | 0.08 | +5.57% |
| Q2 2024 | 2024-06-30 | 0.88 | −1.47 | −62.54% |
| Q1 2024 | 2024-03-31 | 0.88 | −0.75 | −46.10% |
| Q4 2023 | 2023-12-31 | 1.17 | −0.33 | −22.29% |
| Q3 2023 | 2023-09-30 | 1.36 | −0.37 | −21.35% |
| Q2 2023 | 2023-06-30 | 2.35 | 0.44 | +23.22% |
| Q1 2023 | 2023-03-31 | 1.63 | −0.35 | −17.82% |
| Q4 2022 | 2022-12-31 | 1.50 | −0.41 | −21.57% |
| Q3 2022 | 2022-09-30 | 1.73 | −0.35 | −16.85% |
| Q2 2022 | 2022-06-30 | 1.90 | −0.23 | −10.83% |
| Q1 2022 | 2022-03-31 | 1.98 | 0.31 | +18.29% |
| Q4 2021 | 2021-12-31 | 1.92 | 0.25 | +15.05% |
| Q3 2021 | 2021-09-30 | 2.08 | 0.73 | +53.56% |
| Q2 2021 | 2021-06-30 | 2.13 | 1.01 | +89.78% |
| Q1 2021 | 2021-03-31 | 1.67 | 0.50 | +42.29% |
| Q4 2020 | 2020-12-31 | 1.66 | 0.54 | +48.32% |
| Q3 2020 | 2020-09-30 | 1.36 | 0.19 | +16.07% |
| Q2 2020 | 2020-06-30 | 1.12 | −0.02 | −1.45% |
| Q1 2020 | 2020-03-31 | 1.18 | 0.03 | +3.01% |
| Q4 2019 | 2019-12-31 | 1.12 | −0.39 | −25.62% |
| Q3 2019 | 2019-09-30 | 1.17 | −0.39 | −24.78% |
| Q2 2019 | 2019-06-30 | 1.14 | −0.28 | −19.85% |
| Q1 2019 | 2019-03-31 | 1.14 | −0.23 | −17.06% |
| Q4 2018 | 2018-12-31 | 1.51 | 0.26 | +20.65% |
| Q3 2018 | 2018-09-30 | 1.55 | −0.33 | −17.61% |
| Q2 2018 | 2018-06-30 | 1.42 | 0.03 | +2.21% |
| Q1 2018 | 2018-03-31 | 1.38 | −0.04 | −2.91% |
| Q4 2017 | 2017-12-31 | 1.25 | −0.11 | −7.78% |
| Q3 2017 | 2017-09-30 | 1.89 | 0.50 | +35.91% |
| Q2 2017 | 2017-06-30 | 1.39 | −0.69 | −32.99% |
| Q1 2017 | 2017-03-31 | 1.42 | −0.25 | −15.14% |
| Q4 2016 | 2016-12-31 | 1.36 | −0.19 | −12.01% |
| Q3 2016 | 2016-09-30 | 1.39 | −0.08 | −5.41% |
| Q2 2016 | 2016-06-30 | 2.08 | 0.66 | +46.59% |
| Q1 2016 | 2016-03-31 | 1.67 | 0.02 | +1.34% |
| Q4 2015 | 2015-12-31 | 1.54 | −0.19 | −11.09% |
| Q3 2015 | 2015-09-30 | 1.47 | −0.79 | −34.87% |
| Q2 2015 | 2015-06-30 | 1.42 | −0.70 | −32.89% |
| Q1 2015 | 2015-03-31 | 1.65 | −0.24 | −12.55% |
| Q4 2014 | 2014-12-31 | 1.73 | −0.21 | −10.93% |
| Q3 2014 | 2014-09-30 | 2.25 | 0.47 | +26.45% |
| Q2 2014 | 2014-06-30 | 2.11 | 0.36 | +20.62% |
| Q1 2014 | 2014-03-31 | 1.89 | 0.28 | +17.33% |
| Q4 2013 | 2013-12-31 | 1.95 | 0.59 | +43.85% |
| Q3 2013 | 2013-09-30 | 1.78 | 0.48 | +37.03% |
| Q2 2013 | 2013-06-30 | 1.75 | 0.27 | +18.41% |
| Q1 2013 | 2013-03-31 | 1.61 | 0.20 | +14.25% |
| Q4 2012 | 2012-12-31 | 1.35 | −0.09 | −6.47% |
| Q3 2012 | 2012-09-30 | 1.30 | 0.21 | +19.09% |
| Q2 2012 | 2012-06-30 | 1.48 | 0.42 | +40.08% |
| Q1 2012 | 2012-03-31 | 1.41 | 0.45 | +47.04% |
| Q4 2011 | 2011-12-31 | 1.45 | 0.43 | +41.74% |
| Q3 2011 | 2011-09-30 | 1.09 | 0.09 | +9.50% |
| Q2 2011 | 2011-06-30 | 1.06 | 0.03 | +3.31% |
| Q1 2011 | 2011-03-31 | 0.96 | −0.15 | −13.57% |
| Q4 2010 | 2010-12-31 | 1.02 | 0.10 | +11.11% |
| Q3 2010 | 2010-09-30 | 1.00 | −0.62 | −38.52% |
| Q2 2010 | 2010-06-30 | 1.02 | −0.88 | −46.35% |
| Q1 2010 | 2010-03-31 | 1.11 | — | — |
| Q4 2009 | 2009-12-31 | 0.92 | −0.97 | −51.35% |
| Q3 2009 | 2009-09-30 | 1.62 | — | — |
| Q2 2009 | 2009-06-30 | 1.91 | — | — |
| Q4 2008 | 2008-12-31 | 1.89 | — | — |
Labcorp Holdings current ratio trends
Over the last five fiscal years, Labcorp Holdings's current ratio decreased from 1.66 to 1.42, a change of −0.24. The latest reported quarter, Q2 2026, shows 1.80.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...